FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval
The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.
Overcoming stigma and challenges facing women the tech industry
For Women’s History Month we spoke to four women from BenevolentAI’s Leadership Team and explored the barriers, biases and unfair challenges that remain for women in STEM.
Please don’t use this sentence out of context
BenevolentAI and Stanford University review progress in their AI research partnership, which looks at the role of context in information extraction.
Meet our 2021 intern cohort
We caught up with some of our 2021 cohort to hear about why they chose to #InternAtBenevolent, what they worked on, what they learned and their advice for future interns.
Contact us →
Company Registration: 09781806
Terms & Conditions
Privacy & Cookies Policy
WHAT WE DO
WORKING AT BENEVOLENT
FIND A JOB
NEWS & MEDIA